Curis
CRIS
#11032
Rank
NZ$10.82 M
Marketcap
NZ$1.62
Share price
6.65%
Change (1 day)
-30.37%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): NZ-$16.49

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$25.43. In 2022 the company made an earnings per share (EPS) of NZ-$21.82 a decrease over its 2021 EPS that were of NZ-$17.88.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$16.49-24.4%
2022NZ-$21.8222%
2021NZ-$17.88-25.37%
2020NZ-$23.96-30.93%
2019NZ-$34.69-2.02%
2018NZ-$35.41-37.38%
2017NZ-$56.54-29.73%
2016NZ-$80.47-10%
2015NZ-$89.41138.1%
2014NZ-$37.5540%
2013NZ-$26.82-25%
2012NZ-$35.7666.67%
2011NZ-$21.46-850%
2010NZ$2.86-114.29%
2009NZ-$20.03-26.07%
2008NZ-$27.09-26.28%
2007NZ-$36.758.44%
2006NZ-$33.89-32.68%
2005NZ-$50.34-3.76%
2004NZ-$52.3062.95%
2003NZ-$32.10-93.86%
2002NZ-$522.6039.5%
2001NZ-$374.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.36-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.08-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.64-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$6.19-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.78-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.69-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$6.15-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA